Search

everythinglearnresearchcommunity

for

Search:↓

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Abrocitinib may effectively treat stubborn alopecia universalis.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

CS12192 effectively treats alopecia areata with better safety than current options.

Mesenchymal stem cells and their secretome may offer a safe and effective treatment for systemic lupus erythematosus.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

COVID-19 vaccination may trigger lupus in some people.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

A patient with complete hair loss regrew all her hair using tofacitinib.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Teriflunomide can cause hair thinning.

SM04755 may be an effective topical treatment for psoriasis.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

JAK inhibitors are effective for long-term management of alopecia areata.

These new skin treatments are safer and more effective with minimal side effects.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.